Loading chat...
FL S0392
Resolution
Status
Introduced
1/25/2023
Primary Sponsor
Colleen Burton
Click for details
AI Summary
- Recognizes cardiovascular disease as the leading cause of death in the United States, with approximately 21 million patients diagnosed with atherosclerotic cardiovascular disease (ASCVD) in 2019 and national treatment expenditures projected to rise from $126 billion (2015) to $309 billion by 2035
- Notes that over 1.65 million Florida adults had been diagnosed with ASCVD manifestations (angina, coronary artery disease, stroke, or heart attack) in 2019, and ASCVD was reported as an underlying cause of death for 34,781 Floridians that year
- Highlights that Floridians spend an estimated $9.64 billion annually on direct medical expenses for ASCVD care
- Encourages state agencies, in collaboration with the federal government, to expand comprehensive cardiovascular screening programs to allow earlier identification of patients at risk for cardiovascular events
- Recognizes the Florida Department of Health's HeartHealth+ Program and its partners' efforts in tracking clinical quality measures, implementing team-based care, and linking community resources to clinical services to improve outcomes for ASCVD patients
Legislative Description
Atherosclerotic Cardiovascular Disease
Last Action
Adopted, companion bill(s) passed, see HR 8069 (Adopted)
5/2/2023
Full Bill Text
No bill text available